A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf.
Faculty of 1000 evaluation for Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles
[dataset]
2012
F1000 - Post-publication peer review of the biomedical literature
unpublished
Preserved Fulltext
The use of voriconazole, a trifluorinated antifungal, has been associated with the development of fluoride excess and periostitis/ exostoses. We evaluated a cohort of patients on long-term triazole therapy and found that other fluorinated triazoles (fluconazole and posaconazole) conferred no risk for the development of hyperfluorosis and its complications in our cohort.
doi:10.3410/f.13480962.14859113
fatcat:wiuhlc3zgvcqxl7epq63xpkgiy